Region Hovedstaden
Region Hovedstaden is recorded as a service provider in 45 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 20 of 45 trials · Latest update first
Prediction and Prevention of Bloodstream Infections After Kidney Transplantation – the PREDICT Study
Sponsor Region Hovedstaden
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Unprescribing the Pill to Reassess Symptom and Cognitive Recovery in Depression (UNPRESCRIB-D)
Sponsor Region Hovedstaden
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Prehospital pulse-dose glucocorticoid in patients with STEMI – the PULSE-MI 2 trial
Sponsor Rigshospitalet
- Start (EU)
- Latest update
- Estimated end
- Not reported
Colchicine Assessment of Low-grade Inflammation and Biomarker Response in Atherosclerosis with Targeted Evaluation
Sponsor Region Hovedstaden
- Start (EU)
- Latest update
- Estimated end
- Not reported
A phase II randomised trial investigating the benefit of adjuvant immunotherapy after neoadjuvant chemoimmunotherapy for resectable NSCLC (ADIL)
Sponsor Oslo Universitetssykehus HF
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Efficacy of oral bicarbonate versus placebo on the risk of assisted delivery in nulliparous women with prolonged labour (ProLabour): protocol for a randomized controlled trial
Sponsor Region Hovedstaden
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
A randomised, controlled, parallel group, open-label trial evaluating the impact of treatment with the GLP-1 analogue semaglutide on weight loss in people living with HIV and obesity (SWIFT Study)
Sponsor University College Dublin
- Start (EU)
- Latest update
- Estimated end
- Not reported
Driving under the influence of drugs study (DUID-study) ~ A randomised, controlled, double-blinded clinical trial investigating the influence of abused medicinal drugs on cognitive and driving impairment in healthy adults
Sponsor Koebenhavns Universitet
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
The Role of Serotonin 4 Receptor Agonism in Regulating Mood and Cognition in Women with Depression (RECAP-D)
Sponsor Region Hovedstaden
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
A prospective, open-label, non-randomized, single-center, single-dose, phase II exploratory study of FG001 (an imaging agent) in combination with transoral robotic surgery for oropharyngeal squamous cell carcinoma and neck dissection surgery for oral squamous cell carcinoma with regional lymph node metastases
Sponsor Rigshospitalet
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 - A Randomized Phase III Study Conducted by the Resistant Disease Committee of the International BFM Study Group - IntReALL BCP 2020
Sponsor Charite Universitaetsmedizin Berlin KöR
- Start (EU)
- Not reported
- Latest update
- Estimated end
A randomized, placebo-controlled, blinded, parallel-group clinical trial to assess the efficacy of N-acetylcysteine in adults with acute infections or sepsis and evidence of liver dysfunction: the IMPACT-NAC trial
Sponsor Region Hovedstaden
- Start (EU)
- Latest update
- Estimated end
- Not reported
The RHINOME study
Sponsor Region Hovedstaden
- Start (EU)
- Latest update
- Estimated end
- Not reported
Effects of semaglutide as add-on therapy to sulfonylurea on plasma glucose in individuals with HNF1A- and HNF4A-MODY – A Steno MODERN-MODY project (MM-SEMA)
Sponsor Steno Diabetes Center Copenhagen
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
POISON – PeriOperatIve Safety and Effective Opioid DosiNg in Chronic Opioid Use – a Randomized Clinical Study
Sponsor Region Hovedstaden
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Reduced-dose versus full-dose systemic thrombolysis for high-risk pulmonary embolism: a multicentre, randomised, open-label, blinded-endpoint trial
Sponsor Vaestra Goetalandsregionen
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL.
Sponsor Ospedale Pediatrico Bambino Gesu
- Start (EU)
- Latest update
- Estimated end
COMPASS – COpenhagen MenoPAuSe Study
Sponsor Region Hovedstaden
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
HOVON 168: Epcoritamab in Addition to R-Mini-CHOP Compared to R-Mini-CHOP in Elderly, Frail or Unfit Patients with Diffuse Large B-cell Lymphoma
Sponsor Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Luteal phase support following letrozole treatment in women undergoing intrauterine insemination: a multicenter randomized trial
Sponsor Region Midtjylland
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Region Hovedstaden?
The 2026-10-09 snapshot links Region Hovedstaden to 45 distinct CTIS trials. Recorded services include Clinical monitoring, Laboratory services, Medicinal product management, Project management, among 5 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Region Hovedstaden?
The most frequently recorded therapeutic areas are Cardiology, Haematological Malignancies, Infectious Disease, Endocrinology. Recorded phases include Phase 2, Phase 3, Phase 4. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Region Hovedstaden conducted?
The linked trials record locations in 20 countries, including Denmark, Netherlands, Norway, Sweden, Finland. These are trial locations, not confirmed office locations or countries where Region Hovedstaden delivered services.
What can this page tell me about Region Hovedstaden's trial experience?
Browse 45 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Region Hovedstaden. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Region Hovedstaden